HCW BIOLOGICS INC's ticker is and the CUSIP is 40423R105. A total of 14 filers reported holding HCW BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,766 | -12.0% | 82,600 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $179,242 | +57.2% | 82,600 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $113,988 | -18.2% | 82,600 | +13.8% | 0.00% | -25.0% |
| Q4 2022 | $139,392 | -16.0% | 72,600 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | +3.8% | 72,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $160,000 | +3.2% | 72,600 | +28.3% | 0.00% | +33.3% |
| Q1 2022 | $155,000 | +43.5% | 56,600 | +21.5% | 0.00% | +50.0% |
| Q4 2021 | $108,000 | – | 46,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 56,600 | $155,000 | 0.00% |
| HighTower Advisors, LLC | 215,598 | $588,000 | 0.00% |
| Focused Wealth Management, Inc | 1,000 | $3,000 | 0.00% |
| UBS Group AG | 1,705 | $5,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 51,200 | $140,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 44 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 53,169 | $145,000 | 0.00% |
| STATE STREET CORP | 20,546 | $56,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |